Celon Pharma SA (CLN) — Net Asset Quality Index
Celon Pharma SA (CLN) has a Net Asset Quality Index of 78.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of zł670.73 Million minus total liabilities of zł141.95 Million yields net assets of zł528.78 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Celon Pharma SA total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Celon Pharma SA Net Asset Quality Index Over Time (2012–2025)
This chart shows how Celon Pharma SA's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 78.8%, representing net assets of zł528.78 Million against total assets of zł670.73 Million PLN. For live market cap and overall valuation, see market cap of Celon Pharma SA.
Annual Net Asset Quality Index for Celon Pharma SA (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Celon Pharma SA from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Celon Pharma SA (CLN) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (PLN) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 83.7% | zł382.99 Million | zł457.46 Million | zł74.47 Million | ▲ +1.9 pp |
| 2024 | 81.9% | zł445.21 Million | zł543.79 Million | zł98.59 Million | ▲ +3.6 pp |
| 2023 | 78.3% | zł445.56 Million | zł569.31 Million | zł123.75 Million | ▼ -0.5 pp |
| 2022 | 78.8% | zł479.65 Million | zł608.93 Million | zł129.29 Million | ▲ +0.4 pp |
| 2021 | 78.3% | zł554.00 Million | zł707.14 Million | zł153.14 Million | ▲ +16.6 pp |
| 2020 | 61.8% | zł434.67 Million | zł703.64 Million | zł268.97 Million | ▼ -13.5 pp |
| 2019 | 75.3% | zł445.04 Million | zł591.35 Million | zł146.31 Million | ▼ -4.3 pp |
| 2018 | 79.6% | zł448.73 Million | zł563.67 Million | zł114.94 Million | ▼ -4.2 pp |
| 2017 | 83.8% | zł439.85 Million | zł525.05 Million | zł85.20 Million | ▼ -2.9 pp |
| 2016 | 86.7% | zł402.50 Million | zł464.32 Million | zł61.82 Million | ▲ +26.8 pp |
| 2015 | 59.9% | zł100.82 Million | zł168.29 Million | zł67.47 Million | ▼ -6.1 pp |
| 2014 | 66.0% | zł69.62 Million | zł105.44 Million | zł35.82 Million | ▲ +2.8 pp |
| 2013 | 63.2% | zł52.20 Million | zł82.59 Million | zł30.39 Million | ▼ -16.4 pp |
| 2012 | 79.6% | zł55.57 Million | zł69.80 Million | zł14.22 Million | — |